Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Neurovascular Accessory Devices Pipeline Market Overview

Neurovascular accessories are devices used during neurovascular procedures to aid in the introduction of treatment devices or provide further support during the procedure. Accessories included are microguidewires, microcatheters, and distal access catheters. The Neurovascular Accessory Devices pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·       Microcatheters

·       Microguidewires

·       Distal Access Catheters

Key Territories ·       China

·       United States

·       Europe

·       Israel

·       Australia

Key Regulatory Paths ·       NMPA

·       510(k)

·       CE

·       PMA

·       TGA

Leading Companies ·       Achieva Medical (Shanghai) Co Ltd

·       Acotec Scientific Holdings Ltd

·       Alcyone Therapeutics Inc

·       Anaconda BioMed SL

·       Artiria Medical SA

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Neurovascular Accessory Devices Pipeline Market Segmentation by Segments

Some of the key segments in the Neurovascular Accessory Devices market are microcatheters, microguidewires, and distal access catheters. As of August 2023, Microcatheters is the leading segment in the market.

Neurovascular Accessory Devices Pipeline Market Analysis by Segments, 2023 (%)

Neurovascular Accessory Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segments Insights into the Neurovascular Accessory Devices Pipeline Market, Download a Free Report Sample

Neurovascular Accessory Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Neurovascular Accessory Devices market are the US, China, ,  Europe, Australia, and Israel. As of August 2023, China accounts for the highest number of Neurovascular Accessory Devices pipeline products.

Neurovascular Accessory Devices Pipeline Market Analysis by Territories, 2023 (%)

Neurovascular Accessory Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Neurovascular Accessory Devices Pipeline Market, Download a Free Report Sample

Neurovascular Accessory Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Neurovascular Accessory Devices pipeline market are 510(k), NMPA, CE, PMA, and TGA. As of August 2023, NMPA is the most followed pathway for pipeline products.

Neurovascular Accessory Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Neurovascular Accessory Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Neurovascular Accessory Devices Pipeline Market, Download a Free Report Sample

Neurovascular Accessory Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Neurovascular Accessory Devices pipeline market are Achieva Medical (Shanghai) Co Ltd, Acotec Scientific Holdings Ltd, Alcyone Therapeutics Inc, Anaconda BioMed SL, and Artiria Medical SA among others.

Achieva Medical (Shanghai) Co Ltd Company Overview: Achieva Medical (Shanghai) Co Ltd (Achieva Medical), a subsidiary of Peijia Medical Ltd, is a medical device company. Its products include coils and interventional accessories. The company’s coil products include neurovascular detachable coil, a 3D design of Jasper coil that provides adherent scaffolding in aneurysm cases. Achieva Medical also carries out the development, manufacturing, and marketing the cerebral vascular interventional products. The company’s interventional products are used to treat various diseases including cerebral vascular diseases. It has a production and research and development base in Shanghai and Suzhou, China. Achieva Medical is headquartered in Shanghai, China.

Leading Neurovascular Accessory Devices Companies, 2023

Leading Neurovascular Accessory Devices Companies, 2023

Buy Full Report for More Company Insights into The Neurovascular Accessory Devices Pipeline Market, Download a Free Report Sample

Neurovascular Accessory Devices Pipeline Market Segments

Neurovascular Accessory Devices Pipeline Market Segments Outlook, (% 2023)

  • Microcatheters
  • Microguidewires
  • Distal Access Catheters

Neurovascular Accessory Devices Pipeline Market Territories Outlook, (% 2023)

  • China
  • United States
  • Europe
  • Israel
  • Australia

Neurovascular Accessory Devices Pipeline Market Regulatory Paths Outlook, (% 2023)

  • NMPA
  • 510(k)
  • CE
  • PMA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Neurovascular Accessory Devices under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Neurovascular Accessory Devices and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Neurovascular Accessory Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Achieva Medical (Shanghai) Co Ltd
Acotec Scientific Holdings Ltd
Alcyone Therapeutics Inc
Anaconda BioMed SL
Artiria Medical SA
BaseCamp Vascular
Bendit Technologies Ltd
Boston University School of Medicine
Cerovations LLC
Dongguan TT Medical Inc
EchoGuide Medical, Inc. (Inactive)
Hansen Medical Inc (Inactive)
HeMo Bioengineering Ltd
Hibernia Medical
Irras AB
Medikit Co Ltd
MicroPort NeuroTech Ltd
MicroPort Scientific Corp
Navisonics Inc
Neurosyntec LLC. (Inactive)
NeuroVasc Technologies Inc
North Carolina State University
Occam Design LLC
OrbusNeich
Peijia Medical Ltd
Pennsylvania State University
Q'Apel Medical LLC
Rutgers The State University of New Jersey
Sensome SAS
Shanghai HeartCare Medical Technology Co Ltd
Shanghai Pulse Medical Technology Inc
Shenzhen Century MicroPort Medical Technology Co Ltd
Terumo Corp
Twin Star Medical Inc
University of California Los Angeles
University of California San Diego
University of Pennsylvania
University of Pittsburgh
University of Toledo
Vena Medical
Xtract Medical Inc
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 10

2 Introduction 11

2.1 Neurovascular Accessory Devices Overview 11

3 Products under Development 12

3.1 Neurovascular Accessory Devices – Pipeline Products by Stage of Development 12

3.2 Neurovascular Accessory Devices – Pipeline Products by Segment 13

3.3 Neurovascular Accessory Devices – Pipeline Products by Territory 14

3.4 Neurovascular Accessory Devices – Pipeline Products by Regulatory Path 15

3.5 Neurovascular Accessory Devices – Pipeline Products by Estimated Approval Date 16

3.6 Neurovascular Accessory Devices – Ongoing Clinical Trials 17

4 Neurovascular Accessory Devices – Pipeline Products under Development by Companies 18

4.1 Neurovascular Accessory Devices Companies – Pipeline Products by Stage of Development 18

4.2 Neurovascular Accessory Devices – Pipeline Products by Stage of Development 20

5 Neurovascular Accessory Devices Companies and Product Overview 22

5.1 Achieva Medical (Shanghai) Co Ltd Company Overview 22

5.1.1 Achieva Medical (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

5.2 Acotec Scientific Holdings Ltd Company Overview 25

5.2.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 Alcyone Therapeutics Inc Company Overview 27

5.3.1 Alcyone Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Anaconda BioMed SL Company Overview 28

5.4.1 Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 28

5.5 Artiria Medical SA Company Overview 29

5.5.1 Artiria Medical SA Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 BaseCamp Vascular Company Overview 32

5.6.1 BaseCamp Vascular Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 Bendit Technologies Ltd Company Overview 34

5.7.1 Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.8 Boston University School of Medicine Company Overview 36

5.8.1 Boston University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 Cerovations LLC Company Overview 37

5.9.1 Cerovations LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.10 Dongguan TT Medical Inc Company Overview 38

5.10.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.11 EchoGuide Medical, Inc. (Inactive) Company Overview 39

5.11.1 EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39

5.12 Hansen Medical Inc (Inactive) Company Overview 40

5.12.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 HeMo Bioengineering Ltd Company Overview 41

5.13.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Hibernia Medical Company Overview 42

5.14.1 Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Irras AB Company Overview 43

5.15.1 Irras AB Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 Medikit Co Ltd Company Overview 44

5.16.1 Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.17 MicroPort NeuroTech Ltd Company Overview 47

5.17.1 MicroPort NeuroTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 MicroPort Scientific Corp Company Overview 48

5.18.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 Navisonics Inc Company Overview 49

5.19.1 Navisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 Neurosyntec LLC. (Inactive) Company Overview 50

5.20.1 Neurosyntec LLC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 NeuroVasc Technologies Inc Company Overview 51

5.21.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 North Carolina State University Company Overview 52

5.22.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 Occam Design LLC Company Overview 53

5.23.1 Occam Design LLC Pipeline Products & Ongoing Clinical Trials Overview 53

5.24 OrbusNeich Company Overview 54

5.24.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 Peijia Medical Ltd Company Overview 56

5.25.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.26 Pennsylvania State University Company Overview 57

5.26.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 57

5.27 Q’Apel Medical LLC Company Overview 58

5.27.1 Q’Apel Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.28 Rutgers The State University of New Jersey Company Overview 59

5.28.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 59

5.29 Sensome SAS Company Overview 60

5.29.1 Sensome SAS Pipeline Products & Ongoing Clinical Trials Overview 60

5.30 Shanghai HeartCare Medical Technology Co Ltd Company Overview 64

5.30.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64

5.31 Shanghai Pulse Medical Technology Inc Company Overview 67

5.31.1 Shanghai Pulse Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.32 Shenzhen Century MicroPort Medical Technology Co Ltd Company Overview 68

5.32.1 Shenzhen Century MicroPort Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 68

5.33 Terumo Corp Company Overview 69

5.33.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 69

5.34 Twin Star Medical Inc Company Overview 70

5.34.1 Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.35 University of California Los Angeles Company Overview 71

5.35.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 71

5.36 University of California San Diego Company Overview 72

5.36.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 72

5.37 University of Pennsylvania Company Overview 73

5.37.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 73

5.38 University of Pittsburgh Company Overview 75

5.38.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 75

5.39 University of Toledo Company Overview 76

5.39.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 76

5.40 Vena Medical Company Overview 77

5.40.1 Vena Medical Pipeline Products & Ongoing Clinical Trials Overview 77

5.41 Xtract Medical Inc Company Overview 80

5.41.1 Xtract Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.42 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 81

5.42.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

6 Neurovascular Accessory Devices- Recent Developments 86

6.1 Jul 25, 2023: Johnson & Johnson Medtech India Appoints Anuj Virmani as Managing Director 86

6.2 Jul 11, 2023: Neurocrine Biosciences Announces Appointment of Christine A. Poon to Board of Directors 86

6.3 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 86

6.4 Jun 06, 2023: Zylox-tonbridge Medical Technology Co. Announces Poll Results of the 2022 Annual General Meeting 86

6.5 May 22, 2023: Jersey City Medical Center Unveils New Neuro Interventional Cath Lab 87

6.6 May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023 88

6.7 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 88

6.8 Apr 28, 2023: Raffles Medical Group Announces Resolutions Passed at the 34th Annual General Meeting 89

6.9 Apr 26, 2023: MicroPort announces annual results for 2022 89

6.10 Apr 12, 2023: Medtronic has a layoff in California 89

6.11 Apr 05, 2023: Raffles Medical Group Notice of Annual General Meeting 89

6.12 Mar 30, 2023: Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by

87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 91

6.13 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 93

6.14 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 93

6.15 Feb 14, 2023: Asahi Intecc Announces Consolidated Financial Results for the Six Months Ended December 31, 2022 93

6.16 Jan 17, 2023: Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2022 Financial Results 94

6.17 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 95

6.18 Nov 23, 2022: Medtronic Reports Quarterly Earnings 96

6.19 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 96

6.20 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 101

6.21 Nov 11, 2022: Asahi Intecc Consolidated Financial Results for the Three Months Ended September 30, 2022 102

6.22 Sep 29, 2022: Neurocrine Biosciences Appoints Dr. Ingrid Delaet as Chief Regulatory Officer 102

6.23 Sep 15, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced interim report for 2022 103

6.24 Sep 07, 2022: Medtronic to appear at September investor conferences 103

6.25 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 103

6.26 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 106

7 Appendix 109

7.1 Methodology 109

7.2 About GlobalData 112

7.3 Contact Us 112

7.4 Disclaimer 112

Frequently asked questions

Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.